Financial Advisory Group - ALX ONCOLOGY HLDGS INC ownership

Quarter-by-quarter ownership
Financial Advisory Group ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$150,802
-36.1%
31,4170.0%0.03%
-34.0%
Q2 2023$235,942
+66.2%
31,4170.0%0.05%
+62.1%
Q1 2023$142,005
+40014.4%
31,4170.0%0.03%
-61.3%
Q4 2022$354
-99.9%
31,4170.0%0.08%
+10.3%
Q3 2022$301,000
+18.5%
31,4170.0%0.07%
+25.9%
Q2 2022$254,000
-52.2%
31,4170.0%0.05%
-47.6%
Q1 2022$531,000
-21.3%
31,4170.0%0.10%
-22.6%
Q4 2021$675,000
-70.9%
31,4170.0%0.13%
-74.1%
Q3 2021$2,320,000
-21.5%
31,417
-41.9%
0.51%
-27.3%
Q2 2021$2,955,00054,0410.71%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q4 2023
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$530,392,00062.60%
Logos Global Management LP 3,156,981$172,624,00014.51%
Vivo Capital, LLC 4,220,048$230,752,0009.99%
Foresite Capital Management V, LLC 231,200$12,642,0004.97%
Cormorant Asset Management, LP 889,454$48,635,0001.65%
Board of Trustees of The Leland Stanford Junior University 259,982$14,216,0001.33%
Redmile Group, LLC 914,035$49,979,0000.74%
SPHERA FUNDS MANAGEMENT LTD. 192,728$10,538,0000.71%
Financial Advisory Group 54,041$2,955,0000.71%
Nan Fung Group Holdings Ltd 34,950$1,911,0000.59%
View complete list of ALX ONCOLOGY HLDGS INC shareholders